Go Pro
→ Major Buy Alert Issued for September 30th (From TradeSmith) (Ad)tc pixel Free FRPT Stock Alerts

Freshpet (FRPT) Financials

Freshpet logo
$70.24 +0.56 (+0.80%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Freshpet

Annual Income Statements for Freshpet

This table shows Freshpet's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -3.71 -3.16 -4.19 -11 -1.43 -3.19 -30 -58 -34 47 140
Consolidated Net Income / (Loss)		 -3.71 -3.16 -4.26 -5.36 -1.38 -3.19 -30 -59 -34 47 139
Net Income / (Loss) Continuing Operations		 -3.71 -3.16 -4.26 -5.36 -1.38 -3.19 -30 -59 -34 47 139
Total Pre-Tax Income 		-3.65 -3.09 -4.19 -5.28 -1.24 -3.12 -28 -55 -32 48 71
Total Operating Income		 -3.65 -2.21 -2.75 -4.89 -0.25 -2.00 -25 -52 -30 38 76
Total Gross Profit		 55 60 72 90 114 133 162 186 251 396 450
Total Revenue		 116 130 152 193 246 319 425 595 767 975 1,102
Operating Revenue		 116 130 152 193 246 319 425 595 767 975 1,102
Total Cost of Revenue		 62 69 80 103 132 186 263 409 516 579 652
Operating Cost of Revenue		 62 69 80 103 132 186 263 409 516 579 652
Total Operating Expenses		 58 63 75 95 114 135 187 238 281 358 374
Selling, General & Admin Expense		 58 63 75 95 114 135 187 238 281 358 374
Total Other Income / (Expense), net		 -0.01 -0.88 -1.44 -0.40 -0.99 -1.13 -2.87 -3.50 -1.07 9.52 -4.90
Interest Expense		 0.45 0.70 0.91 0.30 0.99 1.21 2.88 5.21 14 12 14
Interest & Investment Income		 - - - - - - - - 0.00 9.92 0.00
Other Income / (Expense), net		 0.45 -0.18 -0.53 -0.10 0.01 0.09 0.01 1.71 13 12 9.22
Income Tax Expense		 0.06 0.07 0.08 0.08 0.14 0.07 0.16 0.28 0.21 0.60 -68
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - -0.08 5.47 0.05 0.00 0.04 -1.49 - - -1.12
Basic Earnings per Share		 ($0.11) ($0.09) ($0.12) ($0.15) ($0.04) ($0.08) ($0.69) ($1.29) ($0.70) $0.97 $2.85
Weighted Average Basic Shares Outstanding		 33.50M 33.67M 34.49M 35.33M 35.95M 39.76M 42.93M 46.19M 48.16M 48.49M 48.80M
Diluted Earnings per Share		 ($0.11) ($0.09) ($0.12) ($0.15) ($0.04) ($0.08) ($0.69) ($1.29) ($0.70) $0.93 $2.64
Weighted Average Diluted Shares Outstanding		 33.50M 33.67M 34.49M 35.33M 35.95M 39.76M 42.93M 46.19M 48.16M 50.26M 56.04M
Weighted Average Basic & Diluted Shares Outstanding		 33.70M 35.10M 34.90M 36.50M 36.17M 40.72M 43.45M 48.05M 48.29M 48.72M 49.06M

Quarterly Income Statements for Freshpet

This table shows Freshpet's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 14 19 -1.69 12 18 -12 17 102 35 49 19
Consolidated Net Income / (Loss)		 15 19 -1.69 12 18 -13 16 102 34 49 19
Net Income / (Loss) Continuing Operations		 15 19 -1.69 12 18 -13 16 102 34 49 19
Total Pre-Tax Income 		15 19 -1.64 12 19 -13 16 24 43 66 26
Total Operating Income		 15 8.46 -1.75 12 19 -11 18 25 44 4.33 22
Total Gross Profit		 75 88 94 102 112 104 108 114 123 121 129
Total Revenue		 215 224 235 253 263 263 265 289 285 298 306
Operating Revenue		 215 224 235 253 263 263 265 289 285 298 306
Total Cost of Revenue		 141 136 141 151 151 159 156 175 162 177 177
Operating Cost of Revenue		 141 136 141 151 151 159 156 175 162 177 177
Total Operating Expenses		 60 80 96 90 92 115 90 89 79 116 107
Selling, General & Admin Expense		 60 80 96 90 92 115 90 89 79 116 107
Total Other Income / (Expense), net		 0.40 10 0.11 0.08 -0.82 -1.07 -1.55 -1.20 -1.09 61 3.89
Interest Expense		 3.45 3.06 2.75 2.92 3.53 3.46 3.75 3.55 3.36 3.59 3.48
Interest & Investment Income		 - 9.92 0.00 0.00 - - - 0.00 - 62 4.54
Other Income / (Expense), net		 3.85 3.34 2.86 3.00 -7.21 2.39 2.20 2.36 2.27 2.88 2.83
Income Tax Expense		 - 0.05 0.05 0.05 0.44 0.13 -0.10 -78 9.56 17 6.11
Basic Earnings per Share		 $0.32 $0.38 ($0.03) $0.25 $0.37 ($0.26) $0.34 $2.08 $0.69 $0.99 $0.40
Weighted Average Basic Shares Outstanding		 48.16M 48.32M 48.46M 48.51M 48.49M 48.73M 48.78M 48.79M 48.80M 49.06M 49.20M
Diluted Earnings per Share		 $0.32 $0.37 ($0.03) $0.24 $0.35 ($0.26) $0.33 $1.86 $0.71 $0.91 $0.39
Weighted Average Diluted Shares Outstanding		 48.16M 50.05M 48.46M 50.28M 50.26M 48.73M 50.20M 55.88M 56.04M 56.06M 55.81M
Weighted Average Basic & Diluted Shares Outstanding		 48.29M 48.43M 48.48M 48.54M 48.72M 48.78M 48.78M 48.81M 49.06M 49.14M 48.06M

Annual Cash Flow Statements for Freshpet

This table details how cash moves in and out of Freshpet's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -28 -4.12 -2.06 5.37 1.92 58 5.54 60 164 -28 9.34
Net Cash From Operating Activities		 6.74 13 10 19 16 21 0.65 -43 76 154 161
Net Cash From Continuing Operating Activities		 6.74 13 9.94 19 16 21 0.65 -43 76 154 161
Net Income / (Loss) Continuing Operations		 -3.71 -3.16 -4.26 -5.36 -1.38 -3.19 -30 -59 -34 47 139
Consolidated Net Income / (Loss)		 -3.71 -3.16 -4.26 -5.36 -1.38 -3.19 -30 -59 -34 47 139
Depreciation Expense		 7.57 9.89 13 14 16 21 30 35 59 74 90
Amortization Expense		 0.14 0.15 0.43 0.12 0.21 0.83 1.21 0.80 4.06 2.09 2.17
Non-Cash Adjustments To Reconcile Net Income		 3.42 3.49 5.16 7.03 8.92 13 28 34 31 45 29
Changes in Operating Assets and Liabilities, net		 -0.69 2.43 -4.08 2.72 -7.35 -11 -29 -53 16 -14 -99
Net Cash From Investing Activities		 -35 -27 -13 -16 -71 -162 -322 -233 -239 -187 -148
Net Cash From Continuing Investing Activities		 -35 -27 -13 -16 -71 -162 -322 -233 -239 -187 -148
Purchase of Property, Plant & Equipment		 -32 -30 -13 -16 -71 -135 -322 -230 -239 -187 -148
Purchase of Investments		 -7.50 - - 0.00 0.00 -20 0.00 -20 -113 0.00 0.00
Sale and/or Maturity of Investments		 4.25 3.25 - 0.00 0.00 20 0.00 20 113 0.00 0.00
Net Cash From Financing Activities		 0.29 9.77 1.01 3.07 56 199 327 337 327 4.57 -3.04
Net Cash From Continuing Financing Activities		 0.29 9.77 1.01 3.07 56 199 327 337 327 4.57 -3.04
Repayment of Debt		 - -3.00 -15 -6.00 -19 -77 -3.26 -78 -2.03 0.00 0.00
Issuance of Debt		 - 10 7.50 6.00 72 21 0.00 78 394 0.00 0.00
Other Financing Activities, net		 0.29 2.77 8.28 3.07 3.17 2.87 -1.92 -0.97 -64 4.57 -3.04
Cash Interest Paid		 0.33 0.45 0.52 0.18 0.52 1.06 1.73 3.15 9.30 10 12
Cash Income Taxes Paid		 0.06 0.08 0.06 0.07 0.01 0.09 0.18 0.30 0.31 0.19 0.91

Quarterly Cash Flow Statements for Freshpet

This table details how cash moves in and out of Freshpet's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -41 -39 -6.20 23 -5.96 -25 -0.05 31 3.38 103 -31
Net Cash From Operating Activities		 37 5.41 42 56 50 4.81 34 67 55 40 44
Net Cash From Continuing Operating Activities		 37 5.41 42 56 50 4.81 34 67 55 40 44
Net Income / (Loss) Continuing Operations		 15 19 -1.69 12 18 -13 16 102 34 49 19
Consolidated Net Income / (Loss)		 15 19 -1.69 12 18 -13 16 102 34 49 19
Depreciation Expense		 13 16 17 19 21 22 21 24 23 25 25
Amortization Expense		 0.51 0.51 0.52 0.52 0.53 0.54 0.54 0.54 0.55 0.55 0.56
Non-Cash Adjustments To Reconcile Net Income		 3.59 -2.47 20 13 14 21 6.77 6.33 -5.21 -52 2.18
Changes in Operating Assets and Liabilities, net		 4.50 -27 6.54 12 -3.92 -26 -10 -66 3.03 19 -2.77
Net Cash From Investing Activities		 -77 -46 -48 -34 -58 -26 -33 -35 -53 68 -25
Net Cash From Continuing Investing Activities		 -77 -46 -48 -34 -58 -26 -33 -35 -53 68 -25
Purchase of Property, Plant & Equipment		 -77 -46 -48 -34 -58 -26 -33 -35 -53 -28 -30
Divestitures		 - - - - - 0.00 - - - 95 4.54
Net Cash From Financing Activities		 -0.76 2.09 -0.29 0.83 1.93 -3.22 -0.49 -0.65 1.33 -4.78 -50
Net Cash From Continuing Financing Activities		 -0.76 2.09 -0.29 0.83 1.93 -3.22 -0.49 -0.65 1.33 -4.78 -50
Other Financing Activities, net		 -0.76 2.09 -0.29 0.83 1.93 -3.22 -0.49 -0.65 1.33 -4.78 4.58
Cash Interest Paid		 0.61 6.59 0.57 6.60 -3.61 5.95 0.05 5.88 -0.35 6.05 -0.24
Cash Income Taxes Paid		 - - - - - 0.00 - - - 0.21 0.70

Annual Balance Sheets for Freshpet

This table presents Freshpet's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 113 126 134 140 236 434 784 1,125 1,464 1,575 1,778
Total Current Assets		 25 19 27 31 54 109 150 262 427 437 436
Cash & Equivalents		 8.03 3.91 2.18 7.55 9.47 67 73 133 297 269 278
Accounts Receivable		 7.03 8.89 13 12 19 18 35 58 57 68 64
Inventories, net		 6.85 5.40 10 9.32 13 19 36 58 63 81 77
Prepaid Expenses		 0.23 0.74 1.20 1.08 3.28 3.38 5.83 9.78 7.62 16 9.81
Other Current Assets		 - 0.30 0.73 0.68 10 0.91 1.35 3.59 2.84 3.13 7.40
Plant, Property, & Equipment, net		 83 101 101 102 165 281 584 801 0.00 0.00 0.00
Total Noncurrent Assets		 4.91 5.71 6.34 6.91 17 44 50 63 1,037 1,138 1,342
Long-Term Investments		 - - - - 0.00 28 26 25 24 33 33
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - - - - 0.00 69
Other Noncurrent Operating Assets		 4.91 5.71 6.34 6.91 17 16 24 37 1,014 1,104 1,240
Total Liabilities & Shareholders' Equity		 113 126 134 140 236 434 784 1,125 1,464 1,575 1,778
Total Liabilities		 9.15 19 17 18 105 40 65 94 511 520 569
Total Current Liabilities		 9.15 19 17 18 42 33 59 90 89 99 79
Accounts Payable		 6.67 6.88 9.17 9.17 19 16 43 55 36 39 42
Accrued Expenses		 2.48 4.78 7.52 9.05 22 15 15 33 50 56 32
Other Current Liabilities		 - - - - 1.19 1.30 1.38 1.51 3.31 3.44 4.56
Total Noncurrent Liabilities		 0.00 0.00 0.30 0.27 63 7.10 5.71 4.20 422 421 491
Long-Term Debt		 - - - - 54 - - 0.00 393 395 397
Capital Lease Obligations		 - - - - - - - 0.00 26 23 28
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - 0.00 0.09
Other Noncurrent Operating Liabilities		 - - 0.30 0.27 8.41 7.10 5.71 4.20 2.59 2.21 65
Commitments & Contingencies		 - - - - - - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 104 108 117 121 131 394 720 1,032 953 1,055 1,209
Total Preferred & Common Equity		 104 108 117 121 131 394 720 1,032 953 1,055 1,209
Total Common Equity		 104 108 117 121 131 394 720 1,032 953 1,055 1,209
Common Stock		 293 300 313 323 334 600 956 1,326 1,283 1,338 1,351
Retained Earnings		 -189 -192 -196 -201 -203 -206 -236 -295 -329 -282 -143
Accumulated Other Comprehensive Income / (Loss)		 - - 0.08 -0.03 -0.08 -0.08 -0.12 1.37 -0.59 -0.79 0.33
Other Equity Adjustments		 - - - -0.26 - - - -0.26 -0.26 -0.26 -0.26

Quarterly Balance Sheets for Freshpet

This table presents Freshpet's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 1,400 1,410 1,444 1,481 1,506 1,532 1,559 1,647 1,746 1,839 1,812
Total Current Assets		 513 487 462 407 405 421 405 409 424 542 517
Cash & Equivalents		 337 244 338 258 252 275 244 244 275 381 351
Accounts Receivable		 50 52 54 69 68 65 63 60 64 65 65
Inventories, net		 66 65 59 72 73 73 82 91 70 81 87
Prepaid Expenses		 7.75 8.18 8.81 5.76 8.57 5.77 14 11 9.33 7.34 7.74
Other Current Assets		 3.09 3.32 1.99 2.94 3.55 3.13 3.07 3.83 5.46 7.12 6.40
Plant, Property, & Equipment, net		 826 865 925 1,006 0.00 0.00 1,082 0.00 0.00 1,144 1,146
Total Noncurrent Assets		 61 58 57 68 1,101 1,110 71 1,238 1,322 154 149
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - - - 78 53 47
Other Noncurrent Operating Assets		 36 34 34 34 1,068 1,077 38 1,205 1,211 101 102
Total Liabilities & Shareholders' Equity		 1,400 1,410 1,444 1,481 1,506 1,532 1,559 1,647 1,746 1,839 1,812
Total Liabilities		 451 473 506 503 511 510 510 576 567 577 575
Total Current Liabilities		 56 77 84 82 90 89 83 85 77 88 86
Accounts Payable		 26 32 41 47 34 35 43 43 31 35 37
Accrued Expenses		 28 43 39 32 53 50 36 38 41 48 44
Other Current Liabilities		 1.54 1.58 3.49 3.16 3.07 3.37 3.52 4.29 4.42 4.68 4.59
Total Noncurrent Liabilities		 395 395 422 421 421 421 427 491 490 489 489
Long-Term Debt		 392 392 393 394 394 395 396 396 397 398 398
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - - 0.11 0.13
Other Noncurrent Operating Liabilities		 3.80 3.10 2.85 2.33 2.06 2.56 31 66 65 91 91
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 949 938 939 978 996 1,021 1,049 1,072 1,178 1,262 1,238
Total Preferred & Common Equity		 949 938 939 978 996 1,021 1,049 1,072 1,178 1,262 1,238
Total Common Equity		 949 938 939 978 996 1,021 1,049 1,072 1,178 1,262 1,238
Common Stock		 1,268 1,276 1,284 1,289 1,309 1,322 1,345 1,350 1,356 1,357 1,368
Retained Earnings		 -320 -337 -344 -310 -312 -300 -295 -278 -176 -94 -75
Treasury Stock		 - - - - - - - - - - -55
Accumulated Other Comprehensive Income / (Loss)		 1.38 -0.66 -0.96 -0.71 -0.79 -0.18 -0.58 -0.34 -0.42 -0.46 -0.71

Annual Metrics And Ratios for Freshpet

This table displays calculated financial ratios and metrics derived from Freshpet's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 33.91% 11.64% 17.46% 26.83% 27.23% 29.66% 33.47% 39.92% 28.82% 27.16% 13.01%
EBITDA Growth		 117.83% 69.05% 28.81% -6.58% 72.76% 26.21% -64.93% -312.28% 402.62% 178.06% 40.78%
EBIT Growth		 90.21% 25.07% -36.71% -52.23% 95.03% -670.56% -1,189.90% -103.95% 65.36% 386.31% 70.24%
NOPAT Growth		 40.01% 39.28% -24.21% -77.59% 94.82% -689.72% -1,134.38% -110.77% 41.43% 276.05% 296.49%
Net Income Growth		 90.06% 14.83% -34.86% -25.78% 74.20% -130.51% -831.59% -100.32% 43.50% 239.60% 196.51%
EPS Growth		 98.86% 18.18% -33.33% -25.00% 73.33% -100.00% -762.50% -86.96% 45.74% 232.86% 183.87%
Operating Cash Flow Growth		 183.96% 89.94% -19.76% 80.86% -12.16% 29.88% -96.95% -6,781.14% 275.68% 103.17% 4.07%
Free Cash Flow Firm Growth		 -1.82% 29.68% 70.79% 54.57% -2,284.68% -98.62% -173.30% 14.93% 30.69% 59.03% 97.37%
Invested Capital Growth		 38.04% 19.64% 3.47% -0.70% 54.72% 69.65% 107.71% 40.62% 20.47% 11.36% 12.88%
Revenue Q/Q Growth		 5.15% 0.40% 6.36% 6.51% 6.09% 6.26% 7.95% 9.16% 6.91% 5.10% 2.09%
EBITDA Q/Q Growth		 126.85% -7.50% 5.18% 6.66% 31.78% -23.50% -27.04% 37.43% 102.42% 1.40% 17.45%
EBIT Q/Q Growth		 87.15% -174.34% 4.24% 3.94% 92.83% -130.83% -22.54% 11.87% 52.93% -11.64% 41.01%
NOPAT Q/Q Growth		 35.19% -146.86% 2.35% 5.28% 92.19% -124.14% -22.54% 9.68% 35.78% 12.36% 9.48%
Net Income Q/Q Growth		 83.82% -95.85% 6.20% 4.33% 67.52% -167.23% -25.15% 9.64% 35.13% 6.42% 12.71%
EPS Q/Q Growth		 98.50% -125.00% 14.29% -7.14% 69.23% -161.54% -25.45% 11.03% 34.58% 3.33% 15.79%
Operating Cash Flow Q/Q Growth		 1,476.58% 40.83% -3.20% 35.86% 20.60% -18.15% -86.51% 13.02% 53.66% 9.51% 3.04%
Free Cash Flow Firm Q/Q Growth		 0.00% 27.89% 9.41% 43.46% -33.04% -17.05% -26.87% 13.92% 3.91% 19.92% 92.28%
Invested Capital Q/Q Growth		 10.63% 0.31% -0.18% -1.75% 9.70% 9.71% 18.09% 6.38% 5.64% 3.52% 2.08%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.04% 46.54% 47.53% 46.57% 46.45% 41.69% 38.11% 31.25% 32.71% 40.60% 40.80%
EBITDA Margin		 3.89% 5.89% 6.46% 4.76% 6.46% 6.29% 1.65% -2.51% 5.89% 12.88% 16.04%
Operating Margin		 -3.14% -1.71% -1.81% -2.53% -0.10% -0.63% -5.80% -8.73% -3.97% 3.90% 6.87%
EBIT Margin		 -2.75% -1.85% -2.15% -2.58% -0.10% -0.60% -5.79% -8.44% -2.27% 5.11% 7.70%
Profit (Net Income) Margin		 -3.19% -2.44% -2.80% -2.77% -0.56% -1.00% -6.98% -9.99% -4.38% 4.81% 12.63%
Tax Burden Percent		 101.57% 102.12% 101.80% 101.46% 111.62% 102.08% 107.87% 107.23% 106.66% 98.74% 196.60%
Interest Burden Percent		 114.21% 129.13% 127.79% 105.93% 499.60% 163.42% 111.69% 110.36% 180.94% 95.30% 83.37%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.26% -96.60%
Return on Invested Capital (ROIC)		 -3.20% -1.52% -1.71% -2.99% -0.12% -0.59% -3.75% -4.87% -2.21% 3.37% 11.93%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.67% 37.81% -516.59% 36.87% -6.56% 6.55% 9.08% 13.13% 39.21% 12.12% 3.57%
Return on Net Nonoperating Assets (RNNOA)		 -0.38% -1.46% -2.09% -1.51% -0.97% -0.62% -1.58% -1.92% -1.17% 1.30% 0.36%
Return on Equity (ROE)		 -3.58% -2.99% -3.79% -4.50% -1.09% -1.21% -5.33% -6.79% -3.39% 4.67% 12.29%
Cash Return on Invested Capital (CROIC)		 -35.16% -19.41% -5.12% -2.29% -43.09% -52.25% -73.76% -38.63% -20.78% -7.37% -0.17%
Operating Return on Assets (OROA)		 -2.84% -2.00% -2.52% -3.64% -0.13% -0.57% -4.05% -5.26% -1.35% 3.28% 5.06%
Return on Assets (ROA)		 -3.29% -2.64% -3.27% -3.92% -0.74% -0.95% -4.87% -6.23% -2.60% 3.09% 8.30%
Return on Common Equity (ROCE)		 -3.58% -2.99% -3.79% -4.50% -1.09% -1.21% -5.33% -6.79% -3.39% 4.67% 12.29%
Return on Equity Simple (ROE_SIMPLE)		 -3.57% -2.93% -3.65% -4.41% -1.05% -0.81% -4.13% -5.77% -3.53% 4.45% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.55 -1.55 -1.93 -3.42 -0.18 -1.40 -17 -36 -21 38 149
NOPAT Margin		 -2.20% -1.20% -1.26% -1.77% -0.07% -0.44% -4.06% -6.11% -2.78% 3.85% 13.50%
Net Nonoperating Expense Percent (NNEP)		 -4.87% -39.33% 514.89% -39.86% 6.44% -7.14% -12.83% -18.00% -41.42% -8.74% 8.36%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -3.53% -1.55% 2.55% 9.10%
Cost of Revenue to Revenue		 52.96% 53.46% 52.47% 53.43% 53.55% 58.31% 61.89% 68.75% 67.29% 59.40% 59.20%
SG&A Expenses to Revenue		 50.18% 48.25% 49.34% 49.10% 46.55% 42.32% 43.90% 39.98% 36.68% 36.71% 33.93%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 50.18% 48.25% 49.34% 49.10% 46.55% 42.32% 43.90% 39.98% 36.68% 36.71% 33.93%
Earnings before Interest and Taxes (EBIT)		 -3.20 -2.40 -3.28 -4.99 -0.25 -1.91 -25 -50 -17 50 85
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.52 7.64 9.84 9.20 16 20 7.03 -15 45 126 177
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.74 3.19 5.65 9.41 16.25 14.64 5.74 2.46 4.39 6.81 2.46
Price to Tangible Book Value (P/TBV)		 2.74 3.19 5.65 9.41 16.25 14.64 5.74 2.46 4.39 6.81 2.46
Price to Revenue (P/Rev)		 2.45 2.65 4.34 5.91 8.67 18.10 9.72 4.26 5.46 7.37 2.70
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 153.20 21.20
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.65% 4.72%
Enterprise Value to Invested Capital (EV/IC)		 2.95 3.13 5.74 9.97 12.35 18.98 6.50 2.72 4.07 6.23 2.33
Enterprise Value to Revenue (EV/Rev)		 2.35 2.67 4.32 5.88 8.86 17.80 9.48 3.99 5.59 7.49 2.80
Enterprise Value to EBITDA (EV/EBITDA)		 60.46 45.36 66.90 123.47 137.08 283.09 573.99 0.00 94.87 58.18 17.47
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 146.49 36.37
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 194.70 20.76
Enterprise Value to Operating Cash Flow (EV/OCF)		 40.55 27.08 64.11 61.12 133.45 267.79 6,236.73 0.00 56.42 47.35 19.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.06 0.00 0.00 0.41 0.00 0.00 0.00 0.44 0.40 0.35
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.41 0.00 0.00 0.00 0.44 0.40 0.35
Financial Leverage		 -0.23 -0.04 0.00 -0.04 0.15 -0.10 -0.17 -0.15 -0.03 0.11 0.10
Leverage Ratio		 1.09 1.13 1.16 1.15 1.49 1.28 1.09 1.09 1.30 1.51 1.48
Compound Leverage Factor		 1.24 1.46 1.48 1.22 7.43 2.09 1.22 1.20 2.36 1.44 1.23
Debt to Total Capital		 0.00% 6.10% 0.00% 0.00% 29.33% 0.00% 0.00% 0.00% 30.54% 28.39% 26.03%
Short-Term Debt to Total Capital		 0.00% 6.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 29.33% 0.00% 0.00% 0.00% 30.54% 28.39% 26.03%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 93.90% 100.00% 100.00% 70.67% 100.00% 100.00% 100.00% 69.46% 71.61% 73.97%
Debt to EBITDA		 0.00 0.92 0.00 0.00 3.43 0.00 0.00 0.00 9.28 3.33 2.41
Net Debt to EBITDA		 0.00 0.40 0.00 0.00 2.83 0.00 0.00 0.00 2.19 0.93 0.64
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 3.43 0.00 0.00 0.00 9.28 3.33 2.41
Debt to NOPAT		 0.00 -4.51 0.00 0.00 -307.54 0.00 0.00 0.00 -19.67 11.15 2.86
Net Debt to NOPAT		 0.00 -1.99 0.00 0.00 -254.06 0.00 0.00 0.00 -4.63 3.10 0.77
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -307.54 0.00 0.00 0.00 -19.67 11.15 2.86
Altman Z-Score		 17.43 9.89 22.42 36.44 12.10 86.35 38.52 16.40 5.36 9.03 4.04
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.78 1.03 1.62 1.70 1.29 3.29 2.55 2.92 4.79 4.42 5.54
Quick Ratio		 2.00 0.69 0.89 1.09 0.67 2.59 1.82 2.12 3.96 3.41 4.35
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -28 -20 -5.77 -2.62 -63 -124 -339 -289 -200 -82 -2.16
Operating Cash Flow to CapEx		 21.05% 42.75% 78.98% 114.14% 23.10% 15.75% 0.20% -18.79% 31.76% 82.47% 108.35%
Free Cash Flow to Firm to Interest Expense		 -61.80 -28.30 -6.34 -8.86 -63.08 -102.45 -117.75 -55.43 -14.19 -6.69 -0.15
Operating Cash Flow to Interest Expense		 14.82 18.33 11.28 62.75 16.47 17.49 0.22 -8.30 5.39 12.58 11.37
Operating Cash Flow Less CapEx to Interest Expense		 -55.59 -24.55 -3.00 7.77 -54.81 -93.54 -111.54 -52.48 -11.57 -2.68 0.88
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.03 1.08 1.17 1.41 1.31 0.95 0.70 0.62 0.59 0.64 0.66
Accounts Receivable Turnover		 18.75 16.30 14.10 15.43 15.91 17.22 15.99 12.89 13.42 15.58 16.67
Inventory Turnover		 8.69 11.31 10.30 10.62 12.05 11.74 9.63 8.72 8.49 8.04 8.28
Fixed Asset Turnover		 1.65 1.41 1.51 1.91 1.84 1.43 0.98 0.86 0.00 0.00 0.00
Accounts Payable Turnover		 10.18 10.23 9.96 11.26 9.46 10.59 8.92 8.38 11.32 15.39 15.99
Days Sales Outstanding (DSO)		 19.46 22.40 25.88 23.66 22.94 21.19 22.83 28.31 27.21 23.43 21.89
Days Inventory Outstanding (DIO)		 42.02 32.26 35.43 34.35 30.30 31.09 37.90 41.85 42.98 45.38 44.08
Days Payable Outstanding (DPO)		 35.86 35.67 36.66 32.42 38.58 34.48 40.93 43.56 32.25 23.71 22.82
Cash Conversion Cycle (CCC)		 25.62 18.98 24.66 25.59 14.66 17.80 19.80 26.60 37.94 45.09 43.14
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 93 111 115 114 176 299 621 873 1,052 1,172 1,323
Invested Capital Turnover		 1.45 1.27 1.35 1.69 1.69 1.34 0.92 0.80 0.80 0.88 0.88
Increase / (Decrease) in Invested Capital		 26 18 3.84 -0.80 62 123 322 252 179 120 151
Enterprise Value (EV)		 273 347 658 1,135 2,178 5,675 4,035 2,376 4,284 7,305 3,088
Market Capitalization		 285 344 661 1,143 2,133 5,770 4,134 2,534 4,185 7,189 2,974
Book Value per Share		 $3.10 $3.18 $3.35 $3.42 $3.64 $9.70 $16.59 $21.48 $19.76 $21.74 $24.76
Tangible Book Value per Share		 $3.10 $3.18 $3.35 $3.42 $3.64 $9.70 $16.59 $21.48 $19.76 $21.74 $24.76
Total Capital		 104 115 117 121 186 394 720 1,032 1,373 1,474 1,634
Total Debt		 0.00 7.00 0.00 0.00 54 0.00 0.00 0.00 419 418 425
Total Long-Term Debt		 0.00 0.00 0.00 0.00 54 0.00 0.00 0.00 419 418 425
Net Debt		 -11 3.09 -2.18 -7.55 45 -95 -99 -158 99 116 114
Capital Expenditures (CapEx)		 32 30 13 16 71 135 322 230 239 187 148
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.97 3.67 8.08 5.19 2.87 8.73 19 40 41 69 79
Debt-free Net Working Capital (DFNWC)		 16 7.57 10 13 12 76 91 172 338 338 357
Net Working Capital (NWC)		 16 0.57 10 13 12 76 91 172 338 338 357
Net Nonoperating Expense (NNE)		 1.16 1.61 2.34 1.94 1.21 1.79 12 23 12 -9.40 9.63
Net Nonoperating Obligations (NNO)		 -11 3.09 -2.18 -7.55 45 -95 -99 -158 99 116 114
Total Depreciation and Amortization (D&A)		 7.72 10 13 14 16 22 32 35 63 76 92
Debt-free, Cash-free Net Working Capital to Revenue		 4.27% 2.83% 5.30% 2.68% 1.17% 2.74% 4.37% 6.65% 5.38% 7.13% 7.18%
Debt-free Net Working Capital to Revenue		 13.98% 5.84% 6.74% 6.59% 5.02% 23.83% 21.48% 28.95% 44.09% 34.67% 32.41%
Net Working Capital to Revenue		 13.98% 0.44% 6.74% 6.59% 5.02% 23.83% 21.48% 28.95% 44.09% 34.67% 32.41%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.11) ($0.09) ($0.12) ($0.15) ($0.04) ($0.08) ($0.69) ($1.29) ($0.70) $0.97 $2.85
Adjusted Weighted Average Basic Shares Outstanding		 33.50M 33.67M 34.49M 35.33M 35.95M 39.76M 42.93M 46.19M 48.16M 48.49M 48.80M
Adjusted Diluted Earnings per Share		 ($0.11) ($0.09) ($0.12) ($0.15) ($0.04) ($0.08) ($0.69) ($1.29) ($0.70) $0.93 $2.64
Adjusted Weighted Average Diluted Shares Outstanding		 33.50M 33.67M 34.49M 35.33M 35.95M 39.76M 42.93M 46.19M 48.16M 50.26M 56.04M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 33.54M 33.98M 35.14M 35.64M 36.17M 40.72M 43.45M 48.05M 48.29M 48.72M 49.06M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.55 -1.55 -1.93 -3.42 -0.18 -1.40 -17 -36 -21 38 53
Normalized NOPAT Margin		 -2.20% -1.20% -1.26% -1.77% -0.07% -0.44% -4.06% -6.11% -2.78% 3.85% 4.81%
Pre Tax Income Margin		 -3.14% -2.39% -2.75% -2.73% -0.50% -0.98% -6.47% -9.32% -4.11% 4.87% 6.42%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -7.04 -3.43 -3.60 -16.85 -0.25 -1.58 -8.55 -9.65 -1.24 4.07 6.01
NOPAT to Interest Expense		 -5.62 -2.22 -2.12 -11.55 -0.18 -1.15 -5.99 -6.99 -1.51 3.06 10.54
EBIT Less CapEx to Interest Expense		 -77.46 -46.32 -17.88 -71.83 -71.52 -112.61 -120.32 -53.83 -18.20 -11.19 -4.48
NOPAT Less CapEx to Interest Expense		 -76.04 -45.11 -16.40 -66.53 -71.45 -112.18 -117.75 -51.16 -18.47 -12.20 0.04
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Freshpet

This table displays calculated financial ratios and metrics derived from Freshpet's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 49,057,177.00 49,142,791.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 49,057,177.00 49,142,791.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.99 0.40
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 29.90% 33.62% 28.32% 26.29% 21.95% 17.60% 12.51% 14.00% 8.57% 13.07% 15.45%
EBITDA Growth		 240.96% 1,160.70% 1,307.24% 127.77% 5.35% -53.01% 115.97% 51.81% 59.78% 147.08% 21.65%
EBIT Growth		 2,307.30% 205.60% 108.79% 604.48% -35.07% -177.17% 1,700.45% 82.79% 112.00% 179.24% 22.68%
NOPAT Growth		 1,129.94% 156.04% 89.55% 339.28% 27.03% -195.37% 1,562.51% 800.81% 83.19% 139.77% -7.74%
Net Income Growth		 624.17% 175.05% 90.01% 265.99% 18.52% -168.26% 1,065.53% 754.67% 86.60% 482.04% 19.15%
EPS Growth		 740.00% 171.15% 91.43% 260.00% 9.38% -170.27% 1,200.00% 675.00% 102.86% 450.00% 18.18%
Operating Cash Flow Growth		 253.70% 139.35% 213.96% 43.12% 36.24% -11.08% -20.10% 19.01% 9.40% 738.96% 31.10%
Free Cash Flow Firm Growth		 35.41% 32.08% 9.07% 31.16% 38.63% 57.42% 60.18% 53.99% -15.59% -51.02% 32.49%
Invested Capital Growth		 20.47% 18.87% 19.13% 13.63% 11.36% 5.70% 8.02% 14.47% 12.88% 9.47% 5.38%
Revenue Q/Q Growth		 7.38% 3.91% 5.09% 7.70% 3.69% 0.21% 0.55% 9.13% -1.25% 4.35% 2.67%
EBITDA Q/Q Growth		 114.58% 17.94% -50.03% 80.12% -0.75% -61.08% 210.39% 26.76% 34.60% -53.34% 52.82%
EBIT Q/Q Growth		 735.69% 15.88% -94.88% 1,238.61% -18.18% -174.82% 319.72% 36.26% 71.47% -84.56% 240.16%
NOPAT Q/Q Growth		 400.63% -43.35% -114.52% 1,067.77% 59.61% -142.53% 322.61% 496.08% -67.54% -90.77% 416.45%
Net Income Q/Q Growth		 313.37% 21.66% -109.11% 802.18% 52.35% -170.06% 228.82% 521.56% -66.74% 43.45% -59.83%
EPS Q/Q Growth		 313.33% 15.63% -108.11% 900.00% 45.83% -174.29% 226.92% 463.64% -61.83% 28.17% -57.14%
Operating Cash Flow Q/Q Growth		 -5.68% -85.38% 684.55% 32.27% -10.22% -90.46% 604.93% 97.02% -17.46% -26.82% 10.16%
Free Cash Flow Firm Q/Q Growth		 8.95% -1.87% -9.32% 32.11% 18.83% 29.33% -2.26% 21.55% -103.89% 7.66% 54.29%
Invested Capital Q/Q Growth		 5.64% 5.01% 2.19% 0.24% 3.52% -0.32% 4.43% 6.23% 2.08% -3.33% 0.53%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 34.62% 39.38% 39.94% 40.36% 42.48% 39.43% 40.87% 39.53% 43.28% 40.54% 42.11%
EBITDA Margin		 15.01% 17.03% 8.10% 13.55% 12.97% 5.04% 15.55% 18.06% 24.62% 11.01% 16.38%
Operating Margin		 6.91% 3.78% -0.74% 4.70% 7.38% -4.37% 6.73% 8.62% 15.59% 1.46% 7.10%
EBIT Margin		 8.70% 9.70% 0.47% 5.87% 4.63% -3.46% 7.56% 9.44% 16.39% 2.42% 8.03%
Profit (Net Income) Margin		 7.10% 8.31% -0.72% 4.69% 6.90% -4.82% 6.18% 35.20% 11.86% 16.30% 6.38%
Tax Burden Percent		 100.00% 99.71% 103.29% 99.55% 97.65% 101.07% 100.63% 428.87% 77.96% 73.90% 76.14%
Interest Burden Percent		 81.59% 85.91% -147.61% 80.35% 152.51% 137.99% 81.26% 86.97% 92.81% 909.91% 104.30%
Effective Tax Rate		 0.00% 0.29% 0.00% 0.45% 2.35% 0.00% -0.63% -328.87% 22.04% 26.10% 23.86%
Return on Invested Capital (ROIC)		 5.51% 3.05% -0.44% 4.08% 6.32% -2.73% 6.02% 32.88% 10.74% 1.00% 5.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.18% 21.91% -1.09% 4.13% 5.57% -6.51% 4.91% 28.38% 10.00% 68.11% 8.11%
Return on Net Nonoperating Assets (RNNOA)		 -0.13% 1.23% -0.08% 0.35% 0.60% -0.79% 0.67% 2.94% 1.02% 3.98% 0.69%
Return on Equity (ROE)		 5.38% 4.28% -0.52% 4.43% 6.91% -3.52% 6.69% 35.82% 11.76% 4.98% 5.77%
Cash Return on Invested Capital (CROIC)		 -20.78% -17.29% -16.07% -9.62% -7.37% -4.03% -4.56% -2.30% -0.17% 1.02% 4.55%
Operating Return on Assets (OROA)		 5.15% 5.54% 0.28% 3.66% 2.97% -2.31% 5.00% 6.22% 10.77% 1.62% 5.46%
Return on Assets (ROA)		 4.20% 4.75% -0.43% 2.93% 4.43% -3.22% 4.09% 23.19% 7.79% 10.90% 4.34%
Return on Common Equity (ROCE)		 5.38% 4.28% -0.52% 4.43% 6.91% -3.52% 6.69% 35.82% 11.76% 4.98% 5.77%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 1.00% 2.51% 4.32% 0.00% 1.49% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 15 8.44 -1.23 12 19 -8.05 18 107 35 3.20 17
NOPAT Margin		 6.91% 3.77% -0.52% 4.68% 7.20% -3.06% 6.77% 36.97% 12.15% 1.08% 5.41%
Net Nonoperating Expense Percent (NNEP)		 1.33% -18.86% 0.65% -0.05% 0.74% 3.79% 1.11% 4.51% 0.74% -67.11% -3.02%
Return On Investment Capital (ROIC_SIMPLE)		 1.09% - - - 1.28% -0.56% 1.20% 6.66% 2.12% 0.19% 1.01%
Cost of Revenue to Revenue		 65.38% 60.62% 60.06% 59.64% 57.52% 60.57% 59.13% 60.47% 56.72% 59.46% 57.89%
SG&A Expenses to Revenue		 27.70% 35.60% 40.68% 35.66% 35.10% 43.79% 34.15% 30.91% 27.69% 39.09% 35.01%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 27.70% 35.60% 40.68% 35.66% 35.10% 43.79% 34.15% 30.91% 27.69% 39.09% 35.01%
Earnings before Interest and Taxes (EBIT)		 19 22 1.11 15 12 -9.10 20 27 47 7.21 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 32 38 19 34 34 13 41 52 70 33 50
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.39 5.72 6.29 6.49 6.81 3.86 3.09 2.28 2.46 2.29 2.35
Price to Tangible Book Value (P/TBV)		 4.39 5.72 6.29 6.49 6.81 3.86 3.09 2.28 2.46 2.29 2.35
Price to Revenue (P/Rev)		 5.46 6.79 7.16 7.15 7.37 3.99 3.18 2.49 2.70 2.55 2.47
Price to Earnings (P/E)		 0.00 715.94 271.69 154.12 153.20 259.31 98.43 21.88 21.20 14.37 14.23
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.14% 0.37% 0.65% 0.65% 0.39% 1.02% 4.57% 4.72% 6.96% 7.03%
Enterprise Value to Invested Capital (EV/IC)		 4.07 5.17 5.67 5.96 6.23 3.57 2.84 2.17 2.33 2.28 2.30
Enterprise Value to Revenue (EV/Rev)		 5.59 6.94 7.31 7.27 7.49 4.11 3.32 2.60 2.80 2.56 2.51
Enterprise Value to EBITDA (EV/EBITDA)		 94.87 65.79 61.19 54.44 58.18 37.70 26.09 18.64 17.47 14.82 14.39
Enterprise Value to EBIT (EV/EBIT)		 0.00 229.91 165.72 119.45 146.49 143.98 72.36 46.60 36.37 28.74 27.92
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 443.59 201.87 194.70 241.22 93.55 20.65 20.76 23.64 24.08
Enterprise Value to Operating Cash Flow (EV/OCF)		 56.42 60.12 51.62 47.85 47.35 27.14 23.86 18.00 19.23 14.84 14.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 232.88 51.79
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.44 0.43 0.42 0.41 0.40 0.38 0.40 0.36 0.35 0.32 0.32
Long-Term Debt to Equity		 0.44 0.43 0.42 0.41 0.40 0.38 0.40 0.36 0.35 0.32 0.32
Financial Leverage		 -0.03 0.06 0.07 0.09 0.11 0.12 0.14 0.10 0.10 0.06 0.08
Leverage Ratio		 1.30 1.50 1.51 1.52 1.51 1.50 1.53 1.49 1.48 1.47 1.50
Compound Leverage Factor		 1.06 1.28 -2.23 1.22 2.31 2.07 1.24 1.30 1.37 13.38 1.56
Debt to Total Capital		 30.54% 29.97% 29.59% 29.06% 28.39% 27.38% 28.41% 26.52% 26.03% 23.97% 24.35%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 30.54% 29.97% 29.59% 29.06% 28.39% 27.38% 28.41% 26.52% 26.03% 23.97% 24.35%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 69.46% 70.03% 70.41% 70.94% 71.61% 72.62% 71.59% 73.48% 73.97% 76.03% 75.65%
Debt to EBITDA		 9.28 4.82 4.00 3.38 3.33 3.58 3.20 2.83 2.41 2.03 1.94
Net Debt to EBITDA		 2.19 1.46 1.27 0.89 0.93 1.07 1.12 0.78 0.64 0.08 0.23
Long-Term Debt to EBITDA		 9.28 4.82 4.00 3.38 3.33 3.58 3.20 2.83 2.41 2.03 1.94
Debt to NOPAT		 -19.67 -902.68 29.00 12.53 11.15 22.89 11.49 3.13 2.86 3.23 3.25
Net Debt to NOPAT		 -4.63 -274.23 9.24 3.31 3.10 6.86 4.00 0.86 0.77 0.13 0.39
Long-Term Debt to NOPAT		 -19.67 -902.68 29.00 12.53 11.15 22.89 11.49 3.13 2.86 3.23 3.25
Altman Z-Score		 5.44 7.25 7.91 8.42 8.95 5.39 4.13 3.61 3.97 3.86 3.96
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.79 4.97 4.50 4.72 4.42 4.91 4.81 5.52 5.54 6.18 6.05
Quick Ratio		 3.96 3.98 3.55 3.81 3.41 3.71 3.58 4.42 4.35 5.10 4.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -164 -167 -183 -124 -101 -71 -73 -57 -116 -107 -49
Operating Cash Flow to CapEx		 47.74% 11.63% 87.77% 164.84% 86.45% 18.15% 101.33% 189.65% 103.88% 146.12% 149.45%
Free Cash Flow to Firm to Interest Expense		 -47.52 -54.56 -66.35 -42.40 -28.51 -20.55 -19.39 -16.05 -34.60 -29.94 -14.09
Operating Cash Flow to Interest Expense		 10.72 1.77 15.42 19.19 14.28 1.39 9.04 18.80 16.40 11.25 12.75
Operating Cash Flow Less CapEx to Interest Expense		 -11.74 -13.42 -2.15 7.55 -2.24 -6.27 0.12 8.89 0.61 3.55 4.22
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.59 0.57 0.60 0.62 0.64 0.67 0.66 0.66 0.66 0.67 0.68
Accounts Receivable Turnover		 13.42 13.95 14.58 15.54 15.58 15.47 16.25 16.69 16.67 17.75 18.72
Inventory Turnover		 8.49 7.74 7.97 8.63 8.04 7.84 7.55 9.00 8.28 8.24 7.79
Fixed Asset Turnover		 0.00 0.90 0.00 0.00 0.00 0.97 0.00 0.00 0.00 1.02 0.00
Accounts Payable Turnover		 11.32 14.66 16.62 14.90 15.39 13.50 16.08 19.35 15.99 17.13 17.34
Days Sales Outstanding (DSO)		 27.21 26.16 25.03 23.49 23.43 23.59 22.47 21.87 21.89 20.56 19.49
Days Inventory Outstanding (DIO)		 42.98 47.14 45.78 42.29 45.38 46.57 48.37 40.56 44.08 44.30 46.88
Days Payable Outstanding (DPO)		 32.25 24.90 21.96 24.50 23.71 27.04 22.69 18.86 22.82 21.31 21.05
Cash Conversion Cycle (CCC)		 37.94 48.41 48.86 41.28 45.09 43.12 48.14 43.57 43.14 43.55 45.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,052 1,105 1,129 1,132 1,172 1,168 1,220 1,296 1,323 1,279 1,285
Invested Capital Turnover		 0.80 0.81 0.84 0.87 0.88 0.89 0.89 0.89 0.88 0.93 0.94
Increase / (Decrease) in Invested Capital		 179 175 181 136 120 63 91 164 151 111 66
Enterprise Value (EV)		 4,284 5,716 6,400 6,741 7,305 4,170 3,463 2,806 3,088 2,909 2,953
Market Capitalization		 4,185 5,589 6,266 6,631 7,189 4,052 3,315 2,688 2,974 2,892 2,905
Book Value per Share		 $19.76 $20.24 $20.56 $21.07 $21.74 $21.54 $21.97 $24.16 $24.76 $25.73 $25.19
Tangible Book Value per Share		 $19.76 $20.24 $20.56 $21.07 $21.74 $21.54 $21.97 $24.16 $24.76 $25.73 $25.19
Total Capital		 1,373 1,396 1,414 1,440 1,474 1,445 1,497 1,604 1,634 1,660 1,636
Total Debt		 419 418 418 418 418 396 425 425 425 398 398
Total Long-Term Debt		 419 418 418 418 418 396 425 425 425 398 398
Net Debt		 99 127 133 110 116 119 148 117 114 17 48
Capital Expenditures (CapEx)		 77 46 48 34 58 26 33 35 53 28 30
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 41 67 64 57 69 79 81 72 79 73 81
Debt-free Net Working Capital (DFNWC)		 338 325 315 332 338 323 324 347 357 454 432
Net Working Capital (NWC)		 338 325 315 332 338 323 324 347 357 454 432
Net Nonoperating Expense (NNE)		 -0.40 -10 0.47 -0.04 0.80 4.65 1.56 5.13 0.85 -45 -2.96
Net Nonoperating Obligations (NNO)		 99 127 133 110 116 119 148 117 114 17 48
Total Depreciation and Amortization (D&A)		 14 16 18 19 22 22 21 25 23 26 26
Debt-free, Cash-free Net Working Capital to Revenue		 5.38% 8.15% 7.26% 6.19% 7.13% 7.80% 7.71% 6.69% 7.18% 6.40% 6.86%
Debt-free Net Working Capital to Revenue		 44.09% 39.48% 36.02% 35.79% 34.67% 31.82% 31.05% 32.13% 32.41% 39.96% 36.66%
Net Working Capital to Revenue		 44.09% 39.48% 36.02% 35.79% 34.67% 31.82% 31.05% 32.13% 32.41% 39.96% 36.66%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.32 $0.38 ($0.03) $0.25 $0.37 ($0.26) $0.34 $2.08 $0.69 $0.99 $0.40
Adjusted Weighted Average Basic Shares Outstanding		 48.16M 48.32M 48.46M 48.51M 48.49M 48.73M 48.78M 48.79M 48.80M 49.06M 49.20M
Adjusted Diluted Earnings per Share		 $0.32 $0.37 ($0.03) $0.24 $0.35 ($0.26) $0.33 $1.86 $0.71 $0.91 $0.39
Adjusted Weighted Average Diluted Shares Outstanding		 48.16M 50.05M 48.46M 50.28M 50.26M 48.73M 50.20M 55.88M 56.04M 56.06M 55.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.29M 48.43M 48.48M 48.54M 48.72M 48.78M 48.78M 48.81M 49.06M 49.14M 48.06M
Normalized Net Operating Profit after Tax (NOPAT)		 10 8.44 -1.23 12 19 -8.05 12 17 35 3.20 17
Normalized NOPAT Margin		 4.84% 3.77% -0.52% 4.68% 7.20% -3.06% 4.71% 6.03% 12.15% 1.08% 5.41%
Pre Tax Income Margin		 7.10% 8.33% -0.70% 4.72% 7.06% -4.77% 6.14% 8.21% 15.21% 22.05% 8.38%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 5.43 7.10 0.40 5.09 3.45 -2.63 5.34 7.67 13.91 2.01 7.05
NOPAT to Interest Expense		 4.32 2.76 -0.45 4.06 5.36 -2.33 4.78 30.07 10.32 0.89 4.75
EBIT Less CapEx to Interest Expense		 -17.02 -8.09 -17.16 -6.56 -13.07 -10.29 -3.58 -2.24 -1.88 -5.68 -1.49
NOPAT Less CapEx to Interest Expense		 -18.14 -12.43 -18.01 -7.59 -11.15 -9.99 -4.14 20.15 -5.47 -6.80 -3.79
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Freshpet’s financial performance has improved meaningfully over the reported period. Revenue increased from $167.5 million in Q1 2023 to $305.6 million in Q2 2026. The latest quarter’s revenue was up 15.5% from Q2 2025, while gross profit increased 19.0% to $128.7 million. Gross margin expanded to approximately 42.1% in Q2 2026, compared with 32.3% in Q2 2023, indicating improved pricing, mix, or production efficiency.

Profitability has also shifted from recurring losses to consistent operating income. Freshpet reported a $21.7 million operating profit in Q2 2026, compared with operating losses of $21.5 million in Q1 2023 and $16.8 million in Q2 2023. Net income was $19.5 million in Q2 2026, following $48.5 million in Q1. However, Q1’s result benefited from $61.3 million of interest and investment income, so the Q2 result appears more representative of the company’s underlying operating performance.

Cash generation is improving, although Freshpet remains capital intensive. Operating cash flow rose to $44.4 million in Q2 2026 from $33.9 million in Q2 2025, and quarterly capital spending declined to $29.7 million from $33.4 million. This produced approximately $14.7 million of operating cash flow after capital expenditures. Freshpet ended Q2 with $350.8 million of cash, a strong liquidity position, although cash declined from $381.4 million at the end of Q1 as financing activity used $49.8 million.

  • Strong revenue growth: Quarterly revenue rose from $183.3 million in Q2 2023 to $305.6 million in Q2 2026, demonstrating sustained top-line expansion.
  • Expanding gross margin: Gross margin improved from roughly 32% in Q2 2023 to 42% in Q2 2026, supporting better operating leverage.
  • Improved operating profitability: Operating income has remained positive since Q2 2025 and reached $21.7 million in the latest quarter.
  • Positive and rising operating cash flow: Q2 2026 operating cash flow of $44.4 million exceeded the year-earlier figure and was substantially above the $4.8 million generated in Q1 2024.
  • Better free-cash-flow profile: Q2 2026 operating cash flow exceeded capital expenditures by approximately $14.7 million, compared with only about $4.4 million in Q2 2025.
  • Healthy liquidity: Freshpet held $350.8 million in cash against $85.5 million of current liabilities at Q2 2026, providing a substantial short-term liquidity cushion.
  • Improving retained earnings: Retained earnings improved to a deficit of $74.7 million in Q2 2026 from a deficit of $278.1 million in Q2 2025 and $344.0 million in Q3 2023.
  • Nonrecurring investment income affects comparisons: Q1 2026 net income was boosted by $61.3 million of interest and investment income, while Q2 2026 included only $4.5 million. Investors should focus on operating income and cash flow when assessing the trend.
  • Cash declined during Q2: Cash fell by $30.6 million during the quarter, primarily because financing activity used $49.8 million and investing activity used $25.2 million.
  • Debt remains significant: Long-term debt was approximately $398.4 million at Q2 2026, largely unchanged from prior periods. Although liquidity is strong, Freshpet continues to carry a sizable debt obligation and associated interest costs.
09/04/26 07:32 PM ETAI Generated. May Contain Errors.

Freshpet Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Freshpet's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Freshpet's net income appears to be on an upward trend, with a most recent value of $139.14 million in 2025, falling from -$3.71 million in 2015. The previous period was $46.93 million in 2024. Find out what analysts predict for Freshpet in the coming months.

Freshpet's total operating income in 2025 was $75.67 million, based on the following breakdown:
  • Total Gross Profit: $449.63 million
  • Total Operating Expenses: $373.95 million

Over the last 10 years, Freshpet's total revenue changed from $116.19 million in 2015 to $1.10 billion in 2025, a change of 848.5%.

Freshpet's total liabilities were at $569.12 million at the end of 2025, a 9.5% increase from 2024, and a 6,121.5% increase since 2015.

In the past 10 years, Freshpet's cash and equivalents has ranged from $2.18 million in 2017 to $296.87 million in 2023, and is currently $277.98 million as of their latest financial filing in 2025.

Over the last 10 years, Freshpet's book value per share changed from 3.10 in 2015 to 24.76 in 2025, a change of 698.4%.


Related Companies

Financial statements for NASDAQ:FRPT last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
They're not buying gold. They're buying this.
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Wall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!)
The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Mo...
Weiss Ratings | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel